Key points from article :
Current drugs help manage the symptoms, but do not prevent brain cells dying.
Patients given diabetes drug exenatide as well as their usual medication remained stable over 48 weeks of treatment.
Trial on 62 patients, published in the Lancet.
The drug is being tested in other neurodegenerative diseases including Alzheimer's.
